Patent ID: 6635625
Filing Date: 2003-10-21
Classification: A61K,A61P,Y10S

Abstract:
A composition for oral use with synergistic anti-inflammatory properties in prostate and bladder conditions induced by the activation of mast cells, consequent degranulation of said cells and subsequent secretion of inflammatory biomelecules, comprising: shark cartilage chondroitin sulfate 150 mg; Saphona plant quercetin; 50 mg; shellfish chitin D-glucosamine sulfate, 130 mg; rooster crown sodium hyaluronate, 20 mg; Saphora plant rutin (quercetin glycoside), 100 mg; microfiltered unrefined olive kernel (pit) extract (acidity less than 3% and water less than 5%), 49%; suspending agents 40 mg beeswax and 20 mg lecithin; in soft gel (from pig gelatin) capsules.